Stocktoria
Teva Pharmaceutical Industries Limited TEVA.TA
IL · Tel Aviv Stock Exchange · XTAE · stock · Healthcare · website
Teva Pharmaceutical Industries Limited statistics & valuation
Market cap$114.5B
P / E81.2×
P / S6.6×
P / B14.5×
P / FCF99.8×
Net margin8.2%
Return on equity17.8%
FCF margin6.7%
Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 51.8% | 48.7% | 48.2% | 46.7% |
| Operating margin | 22.9% | 20.3% | 20.2% | 18.0% |
| Net margin | 8.2% | -9.9% | -3.5% | -16.4% |
| FCF margin | 6.7% | 4.5% | 5.3% | 7.0% |
| Return on assets | 3.5% | -4.2% | -1.3% | -5.6% |
| Return on equity | 17.8% | -30.5% | -7.4% | -31.3% |
| Debt / equity | 1.89× | 2.98× | 2.42× | 2.45× |
| Current ratio | 1.04 | 0.98 | 1.02 | 1.05 |
Source: company filings via Yahoo Finance · IL · as of 2025-12-31. Figures in USD; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.